BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20398730)

  • 1. GNAS imprinting and pituitary tumors.
    Mantovani G; Lania AG; Spada A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.
    Mantovani G; Bondioni S; Lania AG; Corbetta S; de Sanctis L; Cappa M; Di Battista E; Chanson P; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3007-9. PubMed ID: 15181091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatotroph Tumors and the Epigenetic Status of the
    Romanet P; Galluso J; Kamenicky P; Hage M; Theodoropoulou M; Roche C; Graillon T; Etchevers HC; De Murat D; Mougel G; Figarella-Branger D; Dufour H; Cuny T; Assié G; Barlier A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment.
    Picard C; Silvy M; Gerard C; Buffat C; Lavaque E; Figarella-Branger D; Dufour H; Gabert J; Beckers A; Brue T; Enjalbert A; Barlier A
    Int J Cancer; 2007 Sep; 121(6):1245-52. PubMed ID: 17514647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
    Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
    J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of pituitary adenomas.
    Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
    Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minireview: GNAS: normal and abnormal functions.
    Weinstein LS; Liu J; Sakamoto A; Xie T; Chen M
    Endocrinology; 2004 Dec; 145(12):5459-64. PubMed ID: 15331575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency.
    Thiele S; Werner R; Ahrens W; Hoppe U; Marschke C; Staedt P; Hiort O
    J Clin Endocrinol Metab; 2007 May; 92(5):1764-8. PubMed ID: 17299070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.
    Weinstein LS; Yu S; Warner DR; Liu J
    Endocr Rev; 2001 Oct; 22(5):675-705. PubMed ID: 11588148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
    Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
    Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads.
    Mantovani G; Ballare E; Giammona E; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4736-40. PubMed ID: 12364467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
    Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imprinting the Gnas locus.
    Plagge A; Kelsey G
    Cytogenet Genome Res; 2006; 113(1-4):178-87. PubMed ID: 16575178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly.
    Hayward BE; Barlier A; Korbonits M; Grossman AB; Jacquet P; Enjalbert A; Bonthron DT
    J Clin Invest; 2001 Mar; 107(6):R31-6. PubMed ID: 11254676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.
    Akintoye SO; Kelly MH; Brillante B; Cherman N; Turner S; Butman JA; Robey PG; Collins MT
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2960-6. PubMed ID: 16720661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
    Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.